Atlas Trials

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide

Clinical trial NCT01543919 · COMPLETED

Trial details

NCT number
NCT01543919
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2012-04-01
Primary completion
2013-09-01
Enrollment
730

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.